Product Center

效果图-玛舒拉沙韦.jpg

Yisuda®Suraxavir Marboxil Tablets

Yisuda®Suraxavir Marboxil Tablets are a novel antiviral medication for the treatment of uncomplicated influenza A and B in previously healthy adolescents aged 12 and above, and adults.

4.jpg

Aurantii® Fructus Immaturus Total Flavonoids Tablet

Aurantii® Fructus Immaturus Total Flavonoids Tablet have good therapeutic effects on common symptoms of functional dyspepsia (such as liver-stomach disharmony, spleen-stomach damp-heat, food stagnation, and spleen-stomach deficiency).

喜炎平注射液.jpg

Xiyanping Injection

Xiyanping Injection is a traditional Chinese medicine injection made from total sulfated andrographolide, a key component of Andrographis paniculata. It is part of the National “12th Five-Year Plan” Major Innovative Drug Discovery Project.

4.jpg

Qingruitan®Brivaracetam Tablets

Brivaracetam is an innovative third-generation antiepileptic drug that selectively targets synaptic vesicle protein 2A (SV2A) with high affinity.

1.jpg

Bangkaxin®Esomeprazole Magnesium Enteric-coated Tablets

Bangkaxin® Esomeprazole Magnesium Enteric-coated Tablets are a new generation of proton pump inhibitors (PPIs), approved as a Class 4 chemical drug. It is the only esomeprazole magnesium enteric-coated tablet in China that is bioequivalent to the original brand. It is clinically used for the prevention and treatment of acid-related diseases such as gastroesophageal reflux disease (GERD), peptic ulcers, stress ulcers, Helicobacter pylori eradication, and drug-induced gastric mucosal injury. It is widely used in clinical practice and is a first-line choice for acid suppression therapy and ulcer prevention and treatment.

7.jpg

Zebeining® Palbociclib Capsuless

Zebeining® Palbociclib Capsuless are an oral CDK4/6 inhibitor that selectively targets and inhibits the activity of the CDK4/6-Cyclin D1 complex. This prevents tumor cells from passing through the G1 to S phase checkpoint, blocking the cell cycle and inhibiting tumor cell proliferation.It is primarily used for the treatment of hormone receptor-positive (HR+), HER2-negative locally advanced or metastatic breast cancer, in combination with aromatase inhibitors as initial endocrine therapy for postmenopausal women.

效果图-玛舒拉沙韦.jpg
4.jpg
喜炎平注射液.jpg
4.jpg
1.jpg
7.jpg

Qingruitan®Brivaracetam Tablets

Brivaracetam is an innovative third-generation antiepileptic drug that selectively targets synaptic vesicle protein 2A (SV2A) with high affinity.

Fudingning® Zonisamide Tablets

Zonisamide (ZNS), also known as zonisamide, is a new antiepileptic drug. Since its launch in Japan in 1989, it has been used for over 30 years and has treated more than a million patients worldwide. Due to its unique chemical structure and broad-spectrum, potent antiepileptic effects, it is effective for both focal and generalized epilepsy, as well as epilepsy syndromes.

Xinkang® Lacosamide Oral Solution

Xinkang® Lacosamide Oral Solution is another new member of Qingfeng Pharmaceutical's antiepileptic drug family, following the launch of lacosamide tablets and injection.

Xinkang® Lacosamide Injection

Xinkang® Lacosamide Injection is the first third-generation novel antiepileptic injection in China and is the only drug that highly selectively targets the slow-inactivated sodium ion channels.

Xinkang® Lacosamide Tablets

Xinkang® Lacosamide Tablets are the first third-generation novel antiepileptic drug in China, approved for market in January 2019. It is now available in over 58 countries including the U.S., EU, Japan, and China, and has been used by over 500,000 epilepsy patients globally.

Langkang® Perampanel Tablets

Langkang® Perampanel Tablets are a third-generation antiepileptic drug (ASM) that non-competitively binds to the AMPA glutamate receptor on postsynaptic neurons.

Xinkun® Sodium Valproate Concentrated Solution for Injection

Xinkun® Sodium Valproate Concentrated Solution for Injection is a classic broad-spectrum anti-epileptic drug.

Qingruike® Pregabalin Oral Solution

Qingruike® Pregabalin Oral Solution contains pregabalin, a calcium channel modulator that targets the α2-δ subunit of voltage-gated calcium channels. Besides relieving pain, it also improves sleep and mood.

You are about to leave the website www.qfyy.com.cn

Continuing to visit this link will redirect you to another unfamiliar domain. Our privacy policy and terms no longer apply. Please be aware of the risks and protect your personal information.

Well. We will not display the risk warning when you exit from www.qfyy.com.cn.